Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 550.0 g/l; liquid hydrocarbon solvent other 371.0 g/l - fungicide - apricot | banana - interplanted with avocados | barley | bent grass in sporting areas | boronia | bowling green of bent grass | - barley leaf scald | base or butt rot - t. paradoxa | black sigatoka | blind seed disease | blossom blight - monilinia fructicola | blossom blight - monilinia laxa | brown rot (blossom phase)- m. fructicola | brown rot (fruit phase) - m. fructicola | cordana leaf spot - cordana johnstonii | crown rust (puccinia coronata) on oats | dollar spot | early leaf spot on peanut | late leaf spot on peanut | leaf rust | leaf smut on poppy | leaf speckle on banana | leaf spot or yellow sigatoka on banana | pineapple disease | powdery mildew - bulmeria graminis | prune rust | rust on boronia | rust on mint | rust on peanut | septoria leaf blotch - suppession | septoria nodorum blotch on wheat | septoria tritici blotch | spot form net blotch - pyrenophora teres | spring dead spot | stem rust | stripe rust | yellow leaf spot on wheat | barley scald | brown rot | butt rot | ceratocystis paradoxa | drechslera spp. | helminthosporium spp. | peanut rust | puccinia recondita f.sp. triti | puccinia triticina | septoria tritici |

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

phibro animal health pty limited - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 550.0 g/kg - antibiotic & related - calf | cattle | pigs | poultry | beef | beef calf | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bu - bacterial enteritis | cholera | chronic respiratory disease | coryza | diptheria | hexamitiasis | infectious sinusitis | infectious synovitis | leptospirosis | mycoplasma hyopneumoniae | pasteurella spp. | piglet pneumonia | pneumonia | salmonellosis | stress | bacterial pneumonia | discharging sinuses | infectious coryza | l. hardjo | l. interrogans | l. pomona | l. tarassovi | ms | pasterellosis | pasteurellosis | post-weaning bacterial enterit | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Canada - inglese - Health Canada

hall laboratories, ltd. - thiamine mononitrate; vitamin b2; nicotinamide; pyridoxine hydrochloride; calcium d-pantothenate; ascorbic acid; vitamin b12 - capsule - 15mg; 10mg; 50mg; 5mg; 10mg; 550mg; 10mcg - thiamine mononitrate 15mg; vitamin b2 10mg; nicotinamide 50mg; pyridoxine hydrochloride 5mg; calcium d-pantothenate 10mg; ascorbic acid 550mg; vitamin b12 10mcg - vitamin b complex

Canada - inglese - Health Canada

vita health products inc - thiamine mononitrate; vitamin b2; nicotinamide; vitamin b6; vitamin b12; calcium d-pantothenate; ascorbic acid - capsule - 15mg; 10mg; 50mg; 5mg; 10mcg; 10mg; 550mg - thiamine mononitrate 15mg; vitamin b2 10mg; nicotinamide 50mg; vitamin b6 5mg; vitamin b12 10mcg; calcium d-pantothenate 10mg; ascorbic acid 550mg - vitamin b complex

Canada - inglese - Health Canada

whitehall-robins inc. - thiamine mononitrate; vitamin b2; pyridoxine hydrochloride; nicotinamide; calcium d-pantothenate; ascorbic acid - capsule - 15mg; 10mg; 5mg; 50mg; 10mg; 550mg - thiamine mononitrate 15mg; vitamin b2 10mg; pyridoxine hydrochloride 5mg; nicotinamide 50mg; calcium d-pantothenate 10mg; ascorbic acid 550mg - vitamin b complex

Stati Uniti - inglese - NLM (National Library of Medicine)

physicians total care, inc. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - pioglitazone hydrochloride 15 mg - actoplus met is a thiazolidinedione and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and metformin or who have inadequate glycemic control on a thiazolidinedione alone or metformin alone. initiation of actoplus met in patients with established new york heart association (nyha) class iii or iv heart failure is contraindicated (see boxed warning ). in addition, actoplus met is contraindicated in patients with: - renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥ 1.5 mg/dl [males], ≥ 1.4 mg/dl [females], or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings, metformin hydrochloride and precautions, general: metformin hydrochloride ). - known hypersensitivity to pioglitazone, metformin or any other component of actop

Stati Uniti - inglese - NLM (National Library of Medicine)

harris pharmaceutical, inc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judg

Stati Uniti - inglese - NLM (National Library of Medicine)

warner chilcott (us), inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline - unii:n12000u13o) - capsule, delayed release pellets - 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of doryx and other antibacterial drugs, doryx should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriological testing indicates appropri

Stati Uniti - inglese - NLM (National Library of Medicine)

avera mckennan hospital - dexmethylphenidate hydrochloride (unii: 1678ok0e08) (dexmethylphenidate - unii:m32rh9mfgp) - dexmethylphenidate hydrochloride 5 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - paliperidone (unii: 838f01t721) (paliperidone - unii:838f01t721) - paliperidone 3 mg - invega ® (paliperidone) extended-release tablets are indicated for the treatment of schizophrenia [see clinical studies (14.1)] . the efficacy of invega ® in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents, as well as one maintenance trial in adults. invega ® (paliperidone) extended-release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and/or antidepressant therapy [see clinical studies (14.2)] . the efficacy of invega ® in schizoaffective disorder was established in two 6-week trials in adults. invega ® is contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the invega ® formulation. hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone. pali